Cooper Companies (COO) Curent Deferred Tax Liability (2010 - 2011)
Cooper Companies (COO) posted Curent Deferred Tax Liability of $300000.0 for Q4 2011, up 50.0% on a QoQ basis from $200000.0 in Q4 2010, and up 50.0% year-over-year from $200000.0 in Q4 2010.
Powered by 
Analysis
Cooper Companies (COO) Curent Deferred Tax Liability (2010 - 2011) Analysis & Trends
Cooper Companies has reported Curent Deferred Tax Liability for 2 years, with the latest figure at $300000.0 in Q4 2011.
- On a quarterly basis, Curent Deferred Tax Liability rose 50.0% year-over-year to $300000.0 in Q4 2011; TTM through Oct 2011 was $300000.0, a 50.0% increase from a year earlier, with the FY2011 full-year figure at $300000.0, up 50.0% from the prior year.
- Curent Deferred Tax Liability was $300000.0 for Q4 2011 at Cooper Companies, up from $200000.0 in the prior quarter.
- The five-year high for Curent Deferred Tax Liability was $300000.0 in Q4 2011, with the low at $200000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | - |